Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/61258
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaninnit Leerapunen_US
dc.contributor.authorRonald R. Hugateen_US
dc.contributor.authorCarrie Y. Inwardsen_US
dc.contributor.authorSean P. Scullyen_US
dc.contributor.authorFranklin H. Simen_US
dc.date.accessioned2018-09-10T04:07:35Z-
dc.date.available2018-09-10T04:07:35Z-
dc.date.issued2007-10-01en_US
dc.identifier.issn15281132en_US
dc.identifier.issn0009921Xen_US
dc.identifier.other2-s2.0-35348880570en_US
dc.identifier.other10.1097/BLO.0b013e318146830fen_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=35348880570&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/61258-
dc.description.abstractWe retrospectively reviewed 70 patients with low-grade (Grade I) chondrosarcoma of the appendicular skeleton treated at the Mayo Clinic from 1980 to 2001. Fifty-four patients underwent wide resections and three patients underwent marginal excision for radiographically aggressive lesions. Thirteen patients were treated with intralesional curettage for more indolent lesions. The mean age of the patients was 43 years (range, 5-85 years) and the minimum followup was 0.2 year (mean, 8.5 years; range, 0.2-22.8 years). Of the patients who had wide resection, one experienced local recurrence and one had metastasis develop. One patient in the group treated with intralesional curettage had local recurrence and metastasis. We observed no difference in overall survival rate between the intralesional curettage group and the wide resection group. Although there was no difference in the treatment outcome between the two groups, patients with more radiographically aggressive lesions underwent more extensive surgery. The data suggest in selected patients less radiographically aggressive Grade I chondrosarcoma can be safely treated with intralesional curettage without compromising patient outcome. Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence. © 2007 Lippincott Williams & Wilkins, Inc.en_US
dc.subjectMedicineen_US
dc.titleSurgical management of conventional grade I chondrosarcoma of long bonesen_US
dc.typeJournalen_US
article.title.sourcetitleClinical Orthopaedics and Related Researchen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsColorado Limb Consultantsen_US
article.stream.affiliationsMayo Clinicen_US
article.stream.affiliationsUniversity of Miami Leonard M. Miller School of Medicineen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.